Case report: Aumolertinib plus gumarontinib in a patient with EGFR mutated non-small-cell lung cancer harboring acquired MET amplification following progression on afatinib plus crizotinib - Hui, Jia-Jun; Ding, Sheng-Jun; Qin, Bao-Dong; Ding, Ning (Frontiers in Pharmacology, 2025)